| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 18, 2024 | Oct 22, 2024 | Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sell | 13.8 | -816 | -100.00% | ✓ | $24.5K |
| Apr 11, 2024 | Apr 15, 2024 | Enliven Therapeutics, Inc. | CHIEF MEDICAL OFFICER | Sell | 7.5 | -20,000 | -100.00% | ✓ | $501.5K |